Skip to main content

Table 1 Baseline characteristics of patients and controls

From: Validity of serum resistin level and Il-6 as prognostic biomarkers of decompensated liver cirrhosis in chronic hepatitis C virus patients

 

Group I (n = 30)

Group II (n = 40)

Group III (n = 20)

Test of sig

p

Sex

 Male

20 (66.7%)

23 (57.5%)

10 (50%)

χ2 = 1.434

0.488

 Female

10 (33.3%)

17 (42.5%)

10 (50%)

Age (years)

58.50 ± 8.44

59.15 ± 9.18

54.05 ± 8.11

F = 2.430

0.094

RBCs (106/ul)

4.16 ± 0.50

3.31 ± 0.66

4.72 ± 0.54

F = 42.80*

 < 0.001*

 Sig. bet. grps

p1 < 0.001*, p2 = 0.004*, p3 < 0.001*

  

WBCs (103/ul)

4.77 ± 1.91

4.38 ± 1.53

5.93 ± 1.29

F = 6.123*

0.003*

 Sig. bet. grps

p1 = 0.586, p2 = 0.040*, p3 = 0.002*

  

Platelets (103/ul)

118.5 ± 30.91

97.40 ± 34.40

293.15 ± 54.90

F = 182.44*

 < 0.001*

 Sig. bet. grps

p1 = 0.069, p2 < 0.001*, p3 < 0.001*

  

AST (U/L)

29 (14–50)

45 (22–186)

20.5 (14–32)

H = 54.26*

 < 0.001*

 Sig. bet. grps

p1 < 0.001*, p2 = 0.011*, p3 < 0.001*

  

ALT (U/L)

25 (11–38)

31 (14–115)

23.5 (19–30)

H = 21.39*

 < 0.001*

 Sig. bet. grps

p1 < 0.001*, p2 = 0.496, p3 < 0.001*

  

S. Albumin (g/dl)

3.85 (3.5–4.9)

2.6 (2.1–3.4)

4.2 (3.6–5.0)

H = 68.546*

 < 0.001*

 Sig. bet. grps

p1 < 0.001*, p2 = 0.131, p3 < 0.001*

  

T. bilirubin (mg/dl)

0.8 (0.2–1.3)

2.4 (0.7–14.1)

0.9 (0.50–1.10)

H = 57.66*

 < 0.001*

 Sig. bet. grps

p1 < 0.001*, p2 = 0.600, p3 < 0.001*

  

INR

1.10 (0.95–1.29)

1.56 (1.12–2.60)

1.0 (0.90–1.18)

H = 68.02*

 < 0.001*

 Sig. bet. grps

p1 < 0.001*, p2 = 0.066, p3 < 0.001*

  

Serum urea (mg/dl)

29 (10–53)

42.5 (9–139)

31.5 (24–44)

H = 10.561*

0.005*

 Sig. bet. grps

p1 = 0.002*, p2 = 0.460, p3 = 0.047*

  

S. creatinine (mg/dl)

0.85 (0.5–1.4)

1.3 (0.6–3.8)

0.9 (0.7–1.3)

H = 19.090*

 < 0.001*

 Sig. bet. grps

p1 < 0.001*, p2 = 0.524, p3 = 0.003*

  

CRP

6.60 (1.30–15.0)

38.90 (6.0–80.0)

4.45 (2.60–6.10)

H = 65.104*

 < 0.001*

 Sig. bet. grps

p1 < 0.001*, p2 = 0.006*, p3 < 0.001*

MELD-NA

10.0 (7.0–14.0)

22.0 (10.0–33.0)

8.0 (6.0–11.0)

Η = 66.551*

 < 0.001*

 Sig. bet. grps

p1 < 0.001*, p2 = 0.042*, p3 < 0.001*

FIB-4

2.82 (2.593.26)

5.72 (2.1920.40)

0.74 (0.481.22)

Η = 60.737*

 < 0.001*

 Sig. bet. Grps

p1 < 0.001*, p2 < 0.001*, p3 < 0.001*

Resistin level (pg/ml)

259.5 (110–410)

638 (236–923)

62 (45–81)

H = 70.53*

 < 0.001*

 Sig. bet. grps

p1 < 0.001*, p2 = 0.001*, p3 < 0.001*

  

IL-6 level (pg/ml)

27 (11–45)

53.5 (17–131)

7.2 (4.9–10.2)

H = 65.96*

 < 0.001*

 Sig. bet. grps

p1 < 0.001*, p2 = 0.001*, p3 < 0.001*

  
  1. p1, p value for comparing group I and group II
  2. p2, p value for comparing group I and group III
  3. p3, p value for comparing group II and group III
  4. RBCs Red blood cells; WBCs White blood cells; AST Aspartate transaminase; ALT Alanine transaminase; INR International normalized ratio; MELD-NA Model of end-stage liver disease; CRP C-reactive protein; F One way ANOVA test; H Kruskal Wallis test
  5. *Statistically significant at p ≤ 0.05